How to read a health economic evaluation
Understand comparators, perspectives, costs, QALYs, incremental ratios and uncertainty in economic studies.
A health economic evaluation compares alternatives in terms of costs and consequences. Its answer depends on the decision being considered, as well as the evidence and assumptions used. Who receives the intervention? What does it replace? Whose costs are included? How far ahead does the analysis look?
Start by looking at that decision before focusing on the final cost-effectiveness ratio. A correct calculation can answer the wrong question if a relevant alternative is missing or the study uses a setting very different from the one in which the decision will be made.
Identify the alternatives and perspective
List the options being compared. Existing care, another active intervention and doing nothing are different possible comparators. Check why the authors chose their comparisons and whether they reflect realistic options available to someone making the decision.
The perspective defines which consequences and costs belong in the analysis. An evaluation concerned with a health service budget may count different costs from one taking a wider societal perspective. Travel, unpaid care and lost working time may be important, but whether they are included must be stated rather than assumed.
Check the location, currency and price year. A cost reported for another country or an earlier period cannot be transferred to a current local decision without considering what the figure represents.
Look beyond the purchase price
The price of an intervention is only one possible cost. Staff time, facilities, training, monitoring, later care and the consequences of adverse events may also differ. The relevant question is the difference in total costs between alternatives over the chosen period.
The time horizon should be long enough to capture important differences. A short study could record the cost of prevention while missing later benefits. A long-term model may capture those benefits, but it must explain how results observed over a shorter period were projected forward.
Where future costs and outcomes are discounted, check the method and its consistency with the study's stated framework. Discounting is a modelling choice that changes the present value assigned to consequences occurring later.
Understand the outcome measure
Cost-effectiveness analysis can express benefit in natural units, such as an event avoided. Cost-utility analysis often uses quality-adjusted life years, or QALYs, to combine the duration of life with a measure of health-related quality of life.
A QALY is a summary for comparing outcomes under specified assumptions. It does not describe every aspect of an individual's experience. Ask how health-related quality of life was measured and valued, what information was missing and whether important consequences were left out.
Calculate an incremental result
Imagine two hypothetical service options. Usual care costs £2,000 per person and produces 4.00 expected QALYs over the analysis period. The alternative costs £2,600 and produces 4.04 expected QALYs over the same period, with both expressed on the same basis.
The additional cost is £600 and the additional benefit is 0.04 QALYs. Dividing £600 by 0.04 gives an incremental cost-effectiveness ratio of £15,000 per additional QALY. These invented figures illustrate the calculation only; they are not prices, evidence or an official decision threshold.
Now suppose a third option costs £2,700 and produces 4.02 QALYs. It costs more and produces less benefit than the £2,600 option. That is simple dominance. With several alternatives, comparisons should follow a coherent incremental analysis rather than selecting a favourable pair in isolation.
Read uncertainty and applicability
Small changes in an estimated benefit can greatly change a ratio. If the additional benefit in the example were 0.02 QALYs instead of 0.04, the same £600 additional cost would produce a ratio of £30,000 per QALY.
Look for sensitivity and scenario analyses addressing uncertain inputs and important structural assumptions. A model should explain its evidence sources and provide enough detail to inspect the calculations. A favourable central estimate is less persuasive when plausible alternatives reverse the result.
CHEERS supports transparent reporting of economic evaluations. It is not a validated scoring system for methodological quality. A useful appraisal asks whether the methods suit the decision, whether costs and outcomes are credible and whether the findings remain useful in the intended setting.
Cost-effectiveness and affordability also differ. An option may offer favourable value per unit of benefit while requiring a substantial total budget. Keep that practical distinction visible when describing the result.
Methodology references
- NICE: Economic evaluation, technology appraisal and highly specialised technologies manual
- CHEERS 2022 statement: updated reporting guidance for health economic evaluations
- NICE: Methodology checklist for economic evaluations